Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

395 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Blood pressure changes after renal denervation at 10 European expert centers.
Persu A, Jin Y, Azizi M, Baelen M, Völz S, Elvan A, Severino F, Rosa J, Adiyaman A, Fadl Elmula FE, Taylor A, Pechère-Bertschi A, Wuerzner G, Jokhaji F, Kahan T, Renkin J, Monge M, Widimský P, Jacobs L, Burnier M, Mark PB, Kjeldsen SE, Andersson B, Sapoval M, Staessen JA; European Network COordinating research on Renal Denervation (ENCOReD). Persu A, et al. Among authors: kahan t. J Hum Hypertens. 2014 Mar;28(3):150-6. doi: 10.1038/jhh.2013.88. Epub 2013 Sep 26. J Hum Hypertens. 2014. PMID: 24067345 Free PMC article.
Regression of left ventricular hypertrophy in human hypertension with irbesartan.
Malmqvist K, Kahan T, Edner M, Held C, Hägg A, Lind L, Müller-Brunotte R, Nyström F, Ohman KP, Osbakken MD, Ostergern J. Malmqvist K, et al. Among authors: kahan t. J Hypertens. 2001 Jun;19(6):1167-76. doi: 10.1097/00004872-200106000-00023. J Hypertens. 2001. PMID: 11403367 Clinical Trial.
Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type 1 antagonist treatment in hypertensive patients.
Kurland L, Melhus H, Karlsson J, Kahan T, Malmqvist K, Ohman KP, Nyström F, Hägg A, Lind L; Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) Trial. Kurland L, et al. Among authors: kahan t. J Hypertens. 2001 Oct;19(10):1783-7. doi: 10.1097/00004872-200110000-00012. J Hypertens. 2001. PMID: 11593098 Clinical Trial.
Nurse-recorded and ambulatory blood pressure predicts treatment-induced reduction of left ventricular hypertrophy equally well in hypertension: results from the Swedish irbesartan left ventricular hypertrophy investigation versus atenolol (SILVHIA) study.
Nyström F, Malmqvist K, Ohman KP, Kahan T. Nyström F, et al. Among authors: kahan t. J Hypertens. 2002 Aug;20(8):1527-33. doi: 10.1097/00004872-200208000-00015. J Hypertens. 2002. PMID: 12172314 Clinical Trial.
395 results